Patent Assignment
Reel/Frame 054075/0269
Assignment of Assignor's Interest
Recorded: 2020-10-16
Pages: 7
Assignor
BRISTOL-MYERS SQUIBB COMPANY
Executed: 2011-09-08
Assignee
EXELIXIS, INC.
210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Properties
(2)
Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms therof for the treatment of cancer
Application:
16/796,250 →
Publication:
US 2020/0190032
Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms therof for the treatment of cancer
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 16, 2020
From: GALLAGHER, WILLIAM P.
To: BRISTOL-MYERS SQUIBB COMPANY
Reel/Frame 054075/0026 →
Assignment of Assignor's Interest
Oct 16, 2020
From: LAMB, PETER
To: EXELIXIS, INC.
Reel/Frame 054075/0425 →
Assignment of Assignor's Interest
Oct 16, 2020
From: PHARMORPHIX
To: EXELIXIS, INC.
Reel/Frame 054075/0753 →
Assignment of Assignor's Interest
Oct 16, 2020
From: BROWN, ADRIAN ST. CLAIR
To: PHARMORPHIX
Reel/Frame 054075/0948 →